Abstract:Background & Aim MSCs are anchorage-dependent cells that require interaction with a substrate for cell survival and active proliferation. Achieving clinically relevant autologous cell doses in vitro requires significant surface area. Microcarriers are a commonly used, high surface area 3D culture solution combined with traditional bioreactors for allogeneic therapies; however, bioreactors are operated at a much larger scale than that required for personalized medicine. Therefore, a solution combining mid-size, fully closed, single use bags from Saint-Gobain's VueLife® product line with commercially available microcarriers is promising for autologous scale expansion of MSCs. As demonstrated here, VueLife® FEP bags are particularly attractive for this application due to the inherent non-stick properties of the FEP, preventing cell and microcarrier adhesion to the bag surface. Methods, Results & Conclusion For this study, human bone marrow-derived MSCs were purchased from RoosterBio Inc. and cultured in RoosterNourish™ MSC-XF medium. To assess donor-dependent variability in the cell culture performance, three individual donors were compared. MSC expansion was performed in Saint-Gobain's VueLife® 32-C bags with Corning® CellBIND® polystyrene microcarriers and Corning® Synthemax™ II-coated dissolvable microcarriers. Protocols for MSC attachment, expansion and harvest were developed for both microcarrier systems. Cell expansion results after 6 days of culture using the microcarriers are summarized in Tables 1+2. Strong donor-dependent variability was observed in the outcome, with expansion results ranging from 4- to 21-fold increase. However, because the CellBIND® beads are not transparent, cell attachment and harvest efficiency cannot be easily tracked by microscopy and may have also impacted the outcome. Cell attachment and expansion was easier to observe on the dissolvable microcarriers, with clear attachment after four hours and full confluence after four days of culture (Figure 1). MSCs showed 24-26-fold expansion for the three donors (Table 2) using the Corning® dissolvable microcarriers. MSC surface marker expression levels were not affected by culture on either microcarrier system in VueLife® bags and comparable to expression in T-175 flasks, as shown by flow cytometry. To support further expansion towards clinically-relevant doses, additional beads and media may be added to the bags. In , MSC expansion can be facilitated using microcarriers in VueLife® FEP bags for patient specific therapies. Results of MSC expansion on Corning's CellBIND® and Synthemax™ II-coated microcarriers after 6 days in culture in Saint-Gobain VueLife® 32-C bags. Results are shown for three tested MSC donors (#164, #172 and #227).

Mapping the microcarrier design pathway to modernise clinical mesenchymal stromal cell expansion

E7-modified Gelatin Microcarriers for Efficient Expansion and Stemness Preservation of Mesenchymal Stem Cells

Application of human mesenchymal and pluripotent stem cell microcarrier cultures in cellular therapy: achievements and future direction

Scalable manufacture of therapeutic mesenchymal stromal cell products on customizable microcarriers in vertical wheel bioreactors that improve direct visualization, product harvest, and cost

Toward a clinical-grade expansion of mesenchymal stem cells from human sources: a microcarrier-based culture system under xeno-free conditions

From “bench to Bedside”: Current Advancement on Large-Scale Production of Mesenchymal Stem Cells

Biomanufacturing of Human Mesenchymal Stem Cells in Cell Therapy: Influence of Microenvironment on Scalable Expansion in Bioreactors

Influence of Microenvironment on Mesenchymal Stem Cell Therapeutic Potency: From Planar Culture to Microcarriers

Implementation of mDoE‐methods to a microcarrier‐based expansion processes for mesenchymal stem cells

Identification of critical process parameters for expansion of clinical grade human Wharton's jelly-derived mesenchymal stromal cells in stirred-tank bioreactors

Metabolic Regulation of Mesenchymal Stem Cell in Expansion and Therapeutic Application

A scalable culture system incorporating microcarrier for specialised mesenchymal stem cells from human embryonic stem cells

Generation and characterization of mesenchymal stromal cells for clinical application

Mesenchymal Stromal Cell Therapeutic Delivery: Translational Challenges to Clinical Application

Large-Scale Expansion of Human Mesenchymal Stem Cells

A simple, cost-effective microfluidic device using a 3D cross-flow T-junction for producing decellularized extracellular matrix-derived microcarriers

A controllable gelatin-based microcarriers fabrication system for the whole procedures of MSCs amplification and tissue engineering

GMP‐grade microcarrier and automated closed industrial scale cell production platform for culture of MSCs

Strategies to enhance immunomodulatory properties and reduce heterogeneity in mesenchymal stromal cells during ex vivo expansion

Microcarrier-based clinical-grade manufacturing of therapeutic Wharton's jelly mesenchymal stromal cells

3D MSC Culture in Saint-Gobain VueLife® FEP Bags Using Microcarriers